294 related articles for article (PubMed ID: 28392220)
1. Modeling Developmental and Tumorigenic Aspects of Trilateral Retinoblastoma via Human Embryonic Stem Cells.
Avior Y; Lezmi E; Yanuka D; Benvenisty N
Stem Cell Reports; 2017 May; 8(5):1354-1365. PubMed ID: 28392220
[TBL] [Abstract][Full Text] [Related]
2. Role of RB1 in human embryonic stem cell-derived retinal organoids.
Zheng C; Schneider JW; Hsieh J
Dev Biol; 2020 Jun; 462(2):197-207. PubMed ID: 32197890
[TBL] [Abstract][Full Text] [Related]
3. Characterization of human-induced pluripotent stem cells carrying homozygous RB1 gene deletion.
Deng X; Iwagawa T; Fukushima M; Watanabe S
Genes Cells; 2020 Jul; 25(7):510-517. PubMed ID: 32277725
[TBL] [Abstract][Full Text] [Related]
4. Biallelic and monoallelic deletion of the RB1 promoter in six isogenic clonal H9 hESC lines.
Döpper H; Horstmann M; Menges J; Bozet M; Kanber D; Steenpass L
Stem Cell Res; 2020 May; 45():101779. PubMed ID: 32268247
[TBL] [Abstract][Full Text] [Related]
5. Generation and characterization of three CRISPR/Cas9 edited RB1 null hiPSC lines for retinoblastoma disease modelling.
Agrawal T; Maddileti S; Mariappan I
Stem Cell Res; 2024 Apr; 76():103373. PubMed ID: 38452707
[TBL] [Abstract][Full Text] [Related]
6. Ectopic intracranial retinoblastoma in a 3.5-month-old infant without eye involvement and without evidence of heritability.
Römer T; Temming P; Lohmann DR; Sturm D; von Deimling A; Sellhaus B; Mull M; Kontny U; Moser O
Pediatr Blood Cancer; 2019 May; 66(5):e27599. PubMed ID: 30604586
[TBL] [Abstract][Full Text] [Related]
7. CRISPR/Cas9 mediated knockout of rb1 and rbl1 leads to rapid and penetrant retinoblastoma development in Xenopus tropicalis.
Naert T; Colpaert R; Van Nieuwenhuysen T; Dimitrakopoulou D; Leoen J; Haustraete J; Boel A; Steyaert W; Lepez T; Deforce D; Willaert A; Creytens D; Vleminckx K
Sci Rep; 2016 Oct; 6():35264. PubMed ID: 27739525
[TBL] [Abstract][Full Text] [Related]
8. Translating RB1 predictive value in clinical cancer therapy: Are we there yet?
Indovina P; Pentimalli F; Conti D; Giordano A
Biochem Pharmacol; 2019 Aug; 166():323-334. PubMed ID: 31176618
[TBL] [Abstract][Full Text] [Related]
9. Generation of two H1 hESC sublines carrying a heterozygous and homozygous knock-out of RB1.
Steenpass L
Stem Cell Res; 2017 Dec; 25():270-273. PubMed ID: 29246572
[TBL] [Abstract][Full Text] [Related]
10. Heterozygous retinoblastoma gene mutation compromises in vitro osteogenesis of adipose mesenchymal stem cells - a temporal gene expression study.
Vincent A; Natarajan V; Khetan V; Krishnakumar S; Parameswaran S
Exp Cell Res; 2020 Nov; 396(1):112263. PubMed ID: 32890459
[TBL] [Abstract][Full Text] [Related]
11. Mature Ovarian Teratoma After Treatment for Unilateral Retinoblastoma With Nonmutated RB1.
Collins B; Corey SJ
J Pediatr Hematol Oncol; 2017 Aug; 39(6):485-486. PubMed ID: 28719514
[No Abstract] [Full Text] [Related]
12. Generation of an induced pluripotent stem cell line (LVPEIi002-A) with heterozygous RB1 mutation using peri-orbital fat derived mesenchymal cells of a patient with inherited retinoblastoma.
Agrawal T; Maddileti S; Verma A; Kaliki S; Mariappan I
Stem Cell Res; 2024 Apr; 76():103329. PubMed ID: 38335663
[TBL] [Abstract][Full Text] [Related]
13. Cells Lacking the
Oser MG; Fonseca R; Chakraborty AA; Brough R; Spektor A; Jennings RB; Flaifel A; Novak JS; Gulati A; Buss E; Younger ST; McBrayer SK; Cowley GS; Bonal DM; Nguyen QD; Brulle-Soumare L; Taylor P; Cairo S; Ryan CJ; Pease EJ; Maratea K; Travers J; Root DE; Signoretti S; Pellman D; Ashton S; Lord CJ; Barry ST; Kaelin WG
Cancer Discov; 2019 Feb; 9(2):230-247. PubMed ID: 30373918
[TBL] [Abstract][Full Text] [Related]
14. Inhibition of high level E2F in a RB1 proficient MYCN overexpressing chicken retinoblastoma model normalizes neoplastic behaviour.
Zhang H; Konjusha D; Rafati N; Tararuk T; Hallböök F
Cell Oncol (Dordr); 2024 Feb; 47(1):209-227. PubMed ID: 37606819
[TBL] [Abstract][Full Text] [Related]
15. Generation of induced pluripotent stem cells (iPSCs) from a retinoblastoma patient carrying a c.2663G>A mutation in RB1 gene.
Zeng S; Liu L; Ouyang Q; Zhao Y; Lin G; Hu L; Li W
Stem Cell Res; 2016 Sep; 17(2):208-211. PubMed ID: 27879208
[TBL] [Abstract][Full Text] [Related]
16. Phosphorylation of pRb: mechanism for RB pathway inactivation in MYCN-amplified retinoblastoma.
Ewens KG; Bhatti TR; Moran KA; Richards-Yutz J; Shields CL; Eagle RC; Ganguly A
Cancer Med; 2017 Mar; 6(3):619-630. PubMed ID: 28211617
[TBL] [Abstract][Full Text] [Related]
17. Identification of stemness in primary retinoblastoma cells by analysis of stem-cell phenotypes and tumorigenicity with culture and xenograft models.
Tang Z; Ma H; Mao Y; Ai S; Zhang P; Nie C; Gao Y; Lu R
Exp Cell Res; 2019 Jun; 379(1):110-118. PubMed ID: 30935947
[TBL] [Abstract][Full Text] [Related]
18. Generation of human embryonic stem cell line with heterozygous RB1 deletion by CRIPSR/Cas9 nickase.
Tu J; Huo Z; Liu M; Wang D; Xu A; Zhou R; Zhu D; Gingold J; Shen J; Zhao R; Lee DF
Stem Cell Res; 2018 Apr; 28():29-32. PubMed ID: 29414415
[TBL] [Abstract][Full Text] [Related]
19. pRB-Depleted Pluripotent Stem Cell Retinal Organoids Recapitulate Cell State Transitions of Retinoblastoma Development and Suggest an Important Role for pRB in Retinal Cell Differentiation.
Rozanska A; Cerna-Chavez R; Queen R; Collin J; Zerti D; Dorgau B; Beh CS; Davey T; Coxhead J; Hussain R; Al-Aama J; Steel DH; Benvenisty N; Armstrong L; Parulekar M; Lako M
Stem Cells Transl Med; 2022 Apr; 11(4):415-433. PubMed ID: 35325233
[TBL] [Abstract][Full Text] [Related]
20. Bilateral retinoblastoma due to a germline mutation of RB1 in a child with down syndrome.
Le Grignou M; Bleriot A; Nizon M; Pacquement H; Houdayer C; Thebaud E; Le Meur G; Isidor B
Ophthalmic Genet; 2019 Feb; 40(1):86. PubMed ID: 30822236
[No Abstract] [Full Text] [Related]
[Next] [New Search]
